N-(4-Methoxyphenyl)-N-(p-chlorobenzoyl)hydrazine
CAS: 16390-07-1
Rif. 3D-FM176935
100mg | Fuori produzione | ||
250mg | Fuori produzione |
Informazioni sul prodotto
- 4-Chloro-1'-(4-methoxyphenyl)benzohydrazide
- 4-Chlorobenzoic acid 1-(4-methoxyphenyl)hydrazide
- 4-chloro-N'-(4-methoxyphenyl)benzohydrazide
- Benzoic acid, 4-chloro-, 1-(4-methoxyphenyl)hydrazide
- Benzoic acid, p-chloro-, 1-(p-methoxyphenyl)hydrazide
- N-(4-Chlorobenzoyl)-N-(4-methoxyphenyl)hydrazine
- N-(p-Chlorobenzoyl)-N-(p-methoxyphenyl)hydrazine
- N-4-Methoxyphenyl-N-4-chlorobenzoylhydrazide
N-(4-Methoxyphenyl)-N-(p-chlorobenzoyl)hydrazine is a nonselective, nonsteroidal anti-inflammatory drug that inhibits the production of inflammatory prostaglandins. It has been shown to inhibit prostate cancer cells in cell-based assays. This drug has a bioisosteric and bioisosteres relationship with piroxicam, which is also a nonselective, nonsteroidal anti-inflammatory. N-(4-Methoxyphenyl)-N-(p-chlorobenzoyl)hydrazine may be useful in the treatment of prostate cancer because it prevents the production of inflammatory prostaglandins.